Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-107
Closed -$27.3K 167
2023
Q1
$27.3K Buy
+107
New +$31.2K 0.05% 123
2022
Q1
Sell
-10,387
Closed -$2.27M 196
2021
Q4
$2.27M Buy
10,387
+399
+4% +$84.8K 0.61% 31
2021
Q3
$2.18M Buy
9,988
+272
+3% +$59.1K 0.62% 31
2021
Q2
$2.05M Sell
9,716
-68
-0.7% -$17K 0.83% 30
2021
Q1
$2.55M Sell
9,784
-69
-0.7% -$15.4K 0.79% 19
2020
Q4
$2.08M Buy
9,853
+94
+1% +$18.4K 0.89% 34
2020
Q3
$2.15M Buy
9,759
+392
+4% +$69K 0.96% 29
2020
Q2
$1.71M Buy
+9,367
New +$1.78M 0.72% 52

Other funds holding CI

Kalos Management's CI Position: Q2 2023 in Review

Kalos Management sold out of Cigna (CI) in Q2 2023, closing a stake of 107 shares — an estimated $27.3K sold.

Kalos Management first reported a position in CI in Q2 2020 and held it in 8 quarters. The position peaked at $2.55M in Q1 2021. 1,489 funds tracked by Wall St. Rank hold CI as of Q2 2023.

  • Kalos Management reported no remaining Cigna position as of Q2 2023 after selling out during the quarter.
  • Kalos Management sold 107 Cigna shares in Q2 2023, an estimated $27.3K.
  • Kalos Management first reported a position in Cigna in Q2 2020 and held it in 8 quarters.
  • Kalos Management's Cigna position peaked at $2.55M in Q1 2021.
  • 1,489 funds tracked by Wall St. Rank held Cigna as of Q2 2023.

Based on Kalos Management's 13F filing for Q2 2023, filed 9 Aug 2023.